Vol. 22.C May - June 2021 | Annals of Hepatology

ISSN: 1665-2681

Annals of Hepatology (AoH) is an international, open access journal published bi-monthly with funds from the Fundación Clínica Médica Sur. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin American Association for the Study of the Liver (ALEH), the Canadian Association for the Study of the Liver (CASL) and the Czech Society of Hepatology (CSH). AoH publishes editorials, opinions, concise reviews, original articles, brief reports, letters to the editor, news from affiliated associations, clinical practice guidelines and summaries of congresses in the field of Hepatology.

Topics covered by AoH include alcoholic liver disease, autoimmune hepatitis, biliary diseases, drug-induced liver injury, genetic liver diseases, NAFLD/NASH and viral hepatitis (HAV, HBV, HCV, HDV, HEV). Our journal seeks to publish articles on basic clinical care and translational research focused on preventing rather than treating the complications of end-stage liver disease.

See more Open Access Option

Indexed in:

Scopus, Web of Science, Medline/PubMed, DOAJ and Conacyt

•
Largest Brazilian study analyzing post-transplant outcomes in HCC patients.
•
Post-transplant overall survival in HCC patients was 63% over five years.
•
HCC recurrence was observed in 8% of patients submitted to liver transplantation.
•
Patients within Brazilian expanded criteria had lower survival than Milan Criteria.
•
Brazilian criteria was inferior to Milan Criteria to predict tumor recurrence.

Open access

Post-liver transplant outcomes in patients with major psychiatric diagnosis in the United States

Satish K. Kedia, Bilal Ali, Yu Jiang, Hassan Arshad, Sanjaya K. Satapathy, Humberto C. Gonzalez

Ann Hepatol. 2021;22C:100311

Open access

Standardization of conventional chemoembolization for hepatocellular carcinoma

Matteo Renzulli, Giuliano Peta, Francesco Vasuri, Giovanni Marasco, Daniele Caretti, Laura Bartalena, Daniele Spinelli, Emanuela Giampalma, ... Rita Golfieri

Ann Hepatol. 2021;22C:278

Open access

Marlen I. Castellanos-Fernández, Susana A. Borges-González, Maria Stepanova, Mirtha E. Infante-Velázquez, Caridad Ruenes-Domech, Sila M. González-Suero, Zaily Dorta-Guridi, Enrique R. Arus-Soler, ... Zobair M. Younossi

Ann Hepatol. 2021;22C:277

Highlights

•
Patient reported outcomes (PROs) are important to understanding the impact a disease from the patients’ point of view.
•
Chronic liver disease (CLD) can carry a high clinical and PRO burden.
•
PRO data are few among patients with CLD who reside in the Latin America and the Caribbean areas.
•
Using valid and reliable PRO instruments, we quantified PROs for patients with CLD living in Cuba.
•
We determined that patients from Cuba with hepatitis C virus and autoimmune liver disease had the worst PRO scores most likely related to more severe underlying liver disease (fibrosis) and/or to extrahepatic manifestations (fatigue, abdominal pain, anxiety, and depression).

Open access

Long noncoding RNA LINC01189 is associated with HCV-hepatocellular carcinoma and regulates cancer cell proliferation and chemoresistance through hsa-miR-155-5p

Ying Yao, Fang Shu, Fang Wang, Xiaoqiang Wang, Zhengshe Guo, Haili Wang, Lu Li, Haigang Lv

Ann Hepatol. 2021;22C:269

Open access

Renal and brain failure predict mortality of patients with acute-on-chronic liver failure admitted to the intensive care unit

Osvely Méndez-Guerrero, Daniel A. Calle-Rodas, Eduardo Cervantes-Alvarez, Elisa Alatorre-Arenas, Juanita Pérez-Escobar, Nalu Navarro-Alvarez, Aldo Torre

Ann Hepatol. 2021;22C:270

Open access

Unexpected findings of hepatitis B and delta infection in northeastern Brazil: A public health alert

Jomar Diogo Costa Nunes, Diego Luz Felipe da Silva, Lena Maria Barros Fonseca, Ilana Mirian Almeida Felipe, Beatriz Rossetti Ferreira, Rodrigo de Carvalho Santana, Ana de Lourdes Candolo Martinelli, Antônio Augusto Moura da Silva, ... Adalgisa de Souza Paiva Ferreira

Ann Hepatol. 2021;22C:272

Open access

Clinical practice guidelines

Brazilian Society of Hepatology and Brazilian College of Radiology practice guidance for the use of elastography in liver diseases

Ana Carolina Cardoso, Cristiane A. Villela-Nogueira, Cláudio de Figueiredo-Mendes, Hilton Leão Filho, Rogério Augusto Pinto Silva, Cristiane Valle Tovo, Hugo Perazzo, Antonio Carlos Matteoni, ... Paulo Lisboa Bittencourt

Ann Hepatol. 2021;22C:100341

Open access

Case report

A fat containing combined neuroendocrine carcinoma and hepatocellular carcinoma in the liver: A case report

Atsuyuki Ikeda, Kentaro Aoki, Tsuyoshi Terashima, Yoshio Itokawa, Hiroyuki Kokuryu

Ann Hepatol. 2021;22C:183

Open access

Tips for TIPS: A combined percutaneous and transjugular approach for intrahepatic portosystemic shunt placement after liver transplant

Ilaria Lenci, Benedetto Neri, Daniele Morosetti, Martina Milana, Giampiero Palmieri, Giuseppe Tisone, Antonio Orlacchio, Mario Angelico, Leonardo Baiocchi

Ann Hepatol. 2021;22C:162

Open access

Letters to the editor

Usefulness of collagen type IV in the detection of significant liver fibrosis in nonalcoholic fatty liver disease

Chaoli Chen, Xiaofei Li, Wu Guolin

Ann Hepatol. 2021;22C:100300

Open access

Reply to: Usefulness of collagen type IV in the detection of significant liver fibrosis in nonalcoholic fatty liver disease

Claudia P. Oliveira

Ann Hepatol. 2021;22C:100319

Open access

Non-invasive diagnosis of non-alcoholic fatty liver disease using an algorithm combining clinical indexes and ultrasonographic measures

Lingzhen Jin, Xiaofei Li

Ann Hepatol. 2021;22C:100301

Open access

Non-invasive diagnosis of non-alcoholic fatty liver disease using an algorithm combining clinical indexes and ultrasonographic measures

Monica C. Preciado-Puga, Yeniley Ruiz-Noa, Juana R. Garcia-Ramirez, Benjamin Jordan-Perez, Serafin Garnelo-Cabañas, Maria L. Lazo de la Vega-Monroy, Karen I. Gutierrez-Aguirre, Lorena R. Ibarra-Reynoso

Ann Hepatol. 2021;22C:100335

Open access